covid 19 vaccine

On 9 November, Pfizer announced in a press release that their COVID-19 vaccine candidate, developed in conjunction with BioNTech, shows 90 % efficacy one week after the second dose was administered. We analyse the situation with the voice of several experts.
0
vaccine

Vaccine development takes a long time, often more than fifteen years. The SARS-CoV-2 pandemic has accelerated the process in record time. This race has only just begun and there is much to be learned in the near future.
0
Cartografia de la COVID-19

Through several maps, the text shows COVID-19's cartography and analyses the environmental factors that may have contributed to its spread.
0
cover trump pandemics management

The problem with the handling of COVID-19 in the United States has been more political than public health-related. When a country has a president who «didn’t know» and thought that «most people didn’t know» that the flu can kill people, what can be expected in terms of the handling of a pandemic?
0
Anthony Fauci pandemics metaphors

Early criticism of COVID-19 rhetoric cautions against the use of war metaphors that can shift us toward authoritarian and nationalistic sentiment, evoking xenophobia and racism.
0
coronavirus fake news

Most of the fake news that circulated on the web before this pandemic concerned health and became far more widespread than the real news. Unfortunately, this phenomenon has escalated with the global COVID-19 crisis.
0
medical staff coronavirus response

In addition to protective isolation, enhanced medical capacity, safer sociality and health oriented economic stimulus, we will need to turn our hearts, hands, and minds to reweaving and strengthening the complex and vital social web.
0
image SARS-COV-2

We need to rethink many aspects of our daily lives, of our values, of our economic and cultural practices; in short, of our coexistence with the rest of nature and, especially, of our respect for non-human animals.
0